2826 - 2850 of 6568 Results
Title
Year
-
OPENTitle: Excess risk of fracture in incident Parkinson’s disease Medicare beneficiariesJournal Name: Injury EpidemiologyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 4End Page: 4Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1186/s40621-025-00643-4Best OA location URL: https://link.springer.com/content/pdf/10.1186/s40621-025-00643-4.pdfCitation Count: 0
-
OPENTitle: Ih Shapes Pathway-Specific Inhibition in the Substantia Nigra Pars ReticulataJournal Name: The Journal of NeurosciencePublisher: Society for NeuroscienceVol: 46Issue #: 23Start Page: e1413252026End Page: e1413252026Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1523/jneurosci.1413-25.2026Best OA location URL: https://doi.org/10.1523/jneurosci.1413-25.2026Citation Count: 0
-
OPENTitle: Adaptive structural changes in the motor cortex and white matter in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 144Issue #: 5Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-022-02488-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-022-02488-3.pdfCitation Count: 50
-
OPENTitle: (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylationJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 1114End Page: 1130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201540514Best OA location URL: http://doi.org/10.15252/embr.201540514Citation Count: 189
-
OPENTitle: Immunosuppressants and risk of Parkinson diseaseJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 5Issue #: 7Start Page: 870End Page: 875Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.580Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.580Citation Count: 90
-
OPENTitle: Decreased vestibular efficacy contributes to abnormal balance in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 440Issue #:Start Page: 120357End Page: 120357Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120357Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9444904Citation Count: 20
-
OPENTitle: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patientsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abg3092Best OA location URL: https://doi.org/10.1126/sciadv.abg3092Citation Count: 112
-
OPENTitle: Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and functionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 78Issue #:Start Page: 100End Page: 114Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2015.03.008Best OA location URL: https://doaj.org/article/e6cfc888a029486e90bd0c862951a4b1Citation Count: 38
-
OPENTitle: Efficient removal of naturally-occurring lipofuscin autofluorescence in human nervous tissue using high-intensity white lightJournal Name: The Journal of PainPublisher: Elsevier BVVol: 30Issue #:Start Page: 105359End Page: 105359Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jpain.2025.105359Best OA location URL: https://doi.org/10.1016/j.jpain.2025.105359Citation Count: 7
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic FailureJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 6Start Page: 1212End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.26089Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8168720Citation Count: 105
-
OPENTitle: Compensatory neural mechanisms in cognitively unimpaired Parkinson diseaseJournal Name: Annals of NeurologyPublisher: WileyVol: 79Issue #: 3Start Page: 448End Page: 463Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ndDOI - Digital Object Identifier: 10.1002/ana.24585Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.24585Citation Count: 74
-
OPENTitle: Development of Chemical Probes for Investigation of Salt-Inducible Kinase Function in VivoJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 11Issue #: 8Start Page: 2105End Page: 2111Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.6b00217Best OA location URL: http://doi.org/10.1021/acschembio.6b00217Citation Count: 87
- Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease2016OPENTitle: Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 7End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-016-0072-9Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0072-9Citation Count: 290
-
OPENTitle: Allogeneic bone marrow-derived mesenchymal stem cells in the aging kidney: secondary results of a Parkinson’s disease clinical trialJournal Name: Stem Cell Research & TherapyPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page: 493End Page: 493Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13287-025-04577-yBest OA location URL: https://stemcellres.biomedcentral.com/counter/pdf/10.1186/s13287-025-04577-yCitation Count: 4
-
OPENTitle: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interactionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 121Issue #:Start Page: 120End Page: 130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018Best OA location URL: https://doaj.org/article/19a02c63148348009be80a883732b055Citation Count: 35
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 41
-
OPENTitle: Cerebral topography of vesicular cholinergic transporter changes in neurologically intact adults: A [18F]FEOBV PET studyJournal Name: Aging BrainPublisher: Elsevier BVVol: 2Issue #:Start Page: 100039End Page: 100039Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbas.2022.100039Best OA location URL: https://doi.org/10.1016/j.nbas.2022.100039Citation Count: 39
-
OPENTitle: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageJournal Name: eBioMedicinePublisher: Elsevier BVVol: 82Issue #:Start Page: 104179End Page: 104179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104179Best OA location URL: http://www.thelancet.com/article/S2352396422003607/pdfCitation Count: 59
-
OPENTitle: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page: 161End Page: 161Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40478-017-0456-2Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-017-0456-2Citation Count: 100
-
OPENTitle: Capturing Differences in the Regulation of LRRK2 Dynamics and Conformational States by Small Molecule Kinase InhibitorsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 18Issue #: 4Start Page: 810End Page: 821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschembio.2c00868Best OA location URL: https://doi.org/10.1021/acschembio.2c00868Citation Count: 20
-
OPENTitle: Integrated multi-omics highlights alterations of gut microbiome functions in prodromal and idiopathic Parkinson’s diseaseJournal Name: MicrobiomePublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 200End Page: 200Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40168-025-02227-2Best OA location URL: https://doi.org/10.1186/s40168-025-02227-2Citation Count: 6
-
OPENTitle: Quantitative proteomics identifies altered O‐GlcNAcylation of structural, synaptic and memory‐associated proteins in Alzheimer's diseaseJournal Name: The Journal of PathologyPublisher: WileyVol: 243Issue #: 1Start Page: 78End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/path.4929Best OA location URL: http://doi.org/10.1002/path.4929Citation Count: 141
-
OPENTitle: Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial designJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 22Issue #:Start Page: 100785End Page: 100785Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2021.100785Best OA location URL: https://doi.org/10.1016/j.conctc.2021.100785Citation Count: 17
-
OPENTitle: Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease DementiaJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 4Start Page: 479End Page: 483Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13451Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13451Citation Count: 29
-
OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3019295Citation Count: 41